Taking a Closer Look At HCA Healthcare Inc. (HCA) Following Its Recent Trade


HCA Healthcare Inc.’s filing revealed that its SVP & Chief Ethics Officer Whalen Kathleen M unloaded Company’s shares for reported $0.46 million on Feb 17. In the deal valued at $263.61 per share,1,734 shares were sold. As a result of this transaction, Whalen Kathleen M now holds 9,962 shares worth roughly $ 2.46 million.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Then, Berres Jennifer sold 4,000 shares, generating $1,020,912 in total proceeds. Upon selling the shares at $255.23, the SVP & Chief Human Res. Officer now owns 7,392 shares.

Before that, RUTHERFORD BILL B sold 30,000 shares. HCA Healthcare Inc. shares valued at $7,745,568 were divested by the CFO and EVP at a price of $258.19 per share. As a result of the transaction, RUTHERFORD BILL B now holds 81,632 shares, worth roughly $20.13 million.

BMO Capital Markets downgraded its HCA Healthcare Inc. [HCA] rating to an Underperform from a a Market perform in a research note published on Friday, July 06, 2022; the price target was decreased to $160 from $233. PT values the company’s stock at a premium of -54.12 to its Friday closing price. A number of analysts have revised their coverage, including Loop Capital’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Bernstein also remained covering HCA and has increased its forecast on May 27, 2022 with a “an Outperform” recommendation from previously “Mkt perform” rating. Wells Fargo started covering the stock on March 29, 2022. It rated HCA as “an Equal weight”.

Price Performance Review of HCA

On Friday, HCA Healthcare Inc. [NYSE:HCA] saw its stock fall -2.19% to $246.60. On the same session, the stock had its day’s lowest price of $245.21, but rose to a high of $254.35. Over the last five days, the stock has lost -1.36%. HCA Healthcare Inc. shares have risen nearly 2.77% since the year began. Nevertheless, the stocks have fallen -6.72% over the past one year. While a 52-week high of $279.02 was reached on 01/23/23, a 52-week low of $164.47 was recorded on 01/03/23. SMA at 50 days reached $252.99, while 200 days put it at $218.92. A total of 1.2 million shares were traded, compared to the trading of 2.52 million shares in the previous session.

Levels Of Support And Resistance For HCA Stock

The 24-hour chart illustrates a support level at 243.09, which if violated will result in even more drops to 239.58. On the upside, there is a resistance level at 252.23. A further resistance level may holdings at 257.86. The Relative Strength Index (RSI) on the 14-day chart is 43.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.49%. Stochastics %K at 42.76% indicates the stock is a holding.

How much short interest is there in HCA Healthcare Inc.?

A steep rise in short interest was recorded in HCA Healthcare Inc. stocks on Jan 12, 2023, dropping by -0.76 million shares to a total of 2.92 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 3.68 million shares. There was a decline of -26.03%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.38% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.78.

HCA Healthcare Inc. [HCA] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 17,042,919 shares, or roughly 6.15% of the outstanding HCA shares. In other words, the investor’s shares have fallen by -143,343 from its previous 13-F filing of 17186262.0. Additionally, Wellington Management Co. LLP increased 2.65% of its stake after which the total value it holdings stand at $3,498,218,014, while Sanders Capital LLC reduced -3.46% of its stake to hold $2.61 billion in the firm. Over the last quarter, BlackRock Fund Advisors sold -335,283 shares of HCA Healthcare Inc., while SSgA Funds Management, Inc. sold -56,956 shares. At present, T. Rowe Price Associates, Inc. is holding 7,039,618 shares valued at $1.71 billion. Harris Associates LP owned 6,670,965 shares of the company at the time of its most recent 13F filing, worth $1.62 billion.

According to FactSet, HCA Healthcare Inc.’s share price will average $281.77 in the next year, based on opinions of analysts polled by the firm. This is up nearly 12.64 percent from its previous closing price of $252.13. Analysts expect HCA Healthcare Inc. stock to reach the higher price of $310.00, while the lowest price estimate is $243.00. However, 25 analysts have rated HCA stock as an Overweight in their predictions for 2023.


Please enter your comment!
Please enter your name here